CID 146421275

Nezulcitinib

Structural Information

Molecular Formula
C30H37N7O2
SMILES
CCC1=C(C=CC(=C1)O)C2=CC3=C(C=C2)C(=NN3)C4=NC5=C(N4)CN([C@@H](C5)C(=O)N6CC(C6)N(C)C)C(C)C
InChI
InChI=1S/C30H37N7O2/c1-6-18-11-21(38)8-10-22(18)19-7-9-23-24(12-19)33-34-28(23)29-31-25-13-27(37(17(2)3)16-26(25)32-29)30(39)36-14-20(15-36)35(4)5/h7-12,17,20,27,38H,6,13-16H2,1-5H3,(H,31,32)(H,33,34)/t27-/m0/s1
InChIKey
VQIIUJSNIKEMCK-MHZLTWQESA-N
Compound name
[3-(dimethylamino)azetidin-1-yl]-[(6S)-2-[6-(2-ethyl-4-hydroxyphenyl)-1H-indazol-3-yl]-5-propan-2-yl-3,4,6,7-tetrahydroimidazo[4,5-c]pyridin-6-yl]methanone
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

3
References

55
Patents

527.3009 Da
Monoisotopic Mass

3.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 528.30818 231.6
[M+Na]+ 550.29012 239.2
[M+NH4]+ 545.33472 231.4
[M+K]+ 566.26406 239.1
[M-H]- 526.29362 232.6
[M+Na-2H]- 548.27557 231.9
[M]+ 527.30035 231.5
[M]- 527.30145 231.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe